Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Verona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, Chara Mastrokalou, Svetlana Miklikova, Marina Cihova, et al.

Journal title: Biomedicine & Pharmacotherapy

Journal number: Volume 147, March 2022, 112662

Journal publisher: Elsevier

Published year: 2022

DOI identifier: 10.1016/j.biopha.2022.112662

ISSN: 1950-6007